Establishment of Salivary Gland Tumors Arising in Salivary Gland‐Specific EWSR1::ATF1 Transgenic Mice
Head & Neck · 2026
DOI: 10.1002/hed.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von Yuri Hirai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, Yokohama, Japan. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, RNA-Binding Protein EWS, Oncogene Proteins, Fusion, Activating Transcription Factor 1. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Yokohama City University Hospital, Advanced Medical Treatment Support System.
Abstract (Originalsprache)
Background
Salivary gland carcinomas are uncommon malignancies with various histological subtypes harboring fusion genes. The EWSR1::ATF 1 fusion gene, resulting from a translocation between chromosomes 12 and 22, is frequently observed in hyalinizing clear cell carcinoma (HCCC). However, the role of this fusion gene in HCCC oncogenesis remains unclear.
Methods
We generated EWSR1::ATF1 transgenic mice by introducing an EWSR1::ATF1 fusion gene with a breakpoint in HCCC. These mice were crossed with Lama parotid secretory protein (PSP)‐Cre transgenic mice, expressing Cre recombinase in salivary glands, to produce salivary gland‐specific EWSR1::ATF1 transgenic mice. Tumor samples were analyzed using Western blotting, histopathology, and RNA sequencing.
Results
We generated salivary gland‐specific EWSR1::ATF1 transgenic mice, and tumors developed in major salivary glands in three mice. These tumors exhibited more malignant characteristics than human HCCC.
Conclusions
These results suggest that salivary gland‐specific expression of EWSR1::ATF1 plays an important role in malignant tumor formation in major salivary glands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, Yokohama, Japan.
- Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
- Department of Urology, School of Medicine, Yokohama City University, Yokohama, Japan.
- Rheumatic Diseases Center, Yokohama City University Medical Center, Yokohama, Japan.
- Department of Ophthalmology, Dokkyo Medical University, Tochigi, Japan.
- Department of Ophthalmology and Visual Science, School of Medicine, Yokohama City University, Yokohama, Japan.
ORCID-Profile: Ryosuke Jikuya, Satoshi Fujii, Toshitaka Nagao, Nobuhiko Oridate
Förderung
- Japan Society for the Promotion of Science
- Yokohama City University Hospital, Advanced Medical Treatment Support System
Zitieren
APA
Hirai, Y., Utsumi, Y., Sano, D., Kuwahara, T., Aizawa, Y., Hatano, T., Hasumi, H., Soejima, Y., Kawagoe, T., Jikuya, R., Mizuki, N., Fujii, S., Nagao, T., & Oridate, N. (2026). Establishment of Salivary Gland Tumors Arising in Salivary Gland‐Specific EWSR1::ATF1 Transgenic Mice. Head & Neck. https://doi.org/10.1002/hed.70289
Vancouver
Hirai Y, Utsumi Y, Sano D, Kuwahara T, Aizawa Y, Hatano T, et al. Establishment of Salivary Gland Tumors Arising in Salivary Gland‐Specific EWSR1::ATF1 Transgenic Mice. Head & Neck. 2026. doi:10.1002/hed.70289
BibTeX
@article{Hirai2026,
author = {Hirai, Yuri and Utsumi, Yoshitaka and Sano, Daisuke and Kuwahara, Tatsu and Aizawa, Yoshihiro and Hatano, Takashi and Hasumi, Hisashi and Soejima, Yutaro and Kawagoe, Tatsukata and Jikuya, Ryosuke and Mizuki, Nobuhisa and Fujii, Satoshi and Nagao, Toshitaka and Oridate, Nobuhiko},
title = {Establishment of Salivary Gland Tumors Arising in Salivary Gland‐Specific EWSR1::ATF1 Transgenic Mice},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70289}
}
EUVIMED